Matriptase 靶点蛋白|抗体药物|临床药物信息 - ACROBiosystems中国

> 【Matriptase】

Matriptase信息

英文名称：Suppressor of tumorigenicity 14 protein
中文名称：
靶点别称：ST14 Transmembrane Serine Protease Matriptase，MT-SP1，SNC19，TMPRSS14，PRSS14，CAP3，HAI，Suppression Of Tumorigenicity 14 (Colon Carcinoma)，Membrane-Type Serine Protease 1，Serine Protease TADG-15，Serine Protease 14，EC 3.4.21.109，Matriptase，Prostamin，TADG15，Suppression Of Tumorigenicity 14 (Colon Carcinoma， Matriptase， Epithin)，Tumor Associated Differentially Expressed Gene 15 Protein，Tumor-Associated Differentially-Expressed Gene 15 Protein，Suppression Of Tumorigenicity 14，Channel–Activating Protein

上市药物数量：0
临床药物数量：0
最高研发阶段：临床前

Matriptase产品列表

筛选结果

产品库

在线 (1)

物种

Human (1)

标签

Tag Free (1)

属性

Protein (1)

标记

Unconjugated (1)

货号	物种	产品描述	蛋白结构	纯度	活性
MAE-H5143	Human	Human Matriptase / ST14 Catalytic Domain Protein, Tag Free (active enzyme)

ACRO质量管理体系

评论(0)

Matriptase分子别名

Matriptase

Matriptase分子背景

Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing; Cleaves various synthetic substrates with Arg or Lys at the P1 position and prefers small side-chain amino acids, such as Ala and Gly, at the P2 position.

扫一扫关注微信公众号获取ACRO最新资讯

ACROBiosystems百普赛斯生物科技股份有限公司

全国：+86 400-682-2521

北京：010-53681107

上海：021-50850665

海外：+1 800-810-0816

邮箱：（产品订购）order.cn@acrobiosystems.com

邮箱：（技术支持）tech.cn@acrobiosystems.com

邮箱：（廉洁合规）lianjie@acrobiosystems.com

地址：北京经济技术开发区宏达北路8号5号楼4层

在线留言

发送

消息提示

请输入您的联系方式,再点击提交！